Development of an optimized activatable MMP-14 targeted SPECT imaging probe

Center for Molecular and Functional Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, 185 Berry Street, Suite 350, Box 0946, San Francisco, CA 94107, United States.
Bioorganic & medicinal chemistry (Impact Factor: 2.79). 01/2009; 17(2):653-9. DOI: 10.1016/j.bmc.2008.11.078
Source: PubMed


Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a membrane-associated protease implicated in a variety of tissue remodeling processes and a molecular hallmark of select metastatic cancers. The ability to detect MMP-14 in vivo would be useful in studying its role in pathologic processes and may potentially serve as a guide for the development of targeted molecular therapies. Four MMP-14 specific probes containing a positively charged cell penetrating peptide (CPP) d-arginine octamer (r(8)) linked with a MMP-14 peptide substrate and attenuating sequences with glutamate (8e, 4e) or glutamate-glycine (4eg and 4egg) repeating units were modeled using an AMBER force field method. The probe with 4egg attenuating sequence exhibited the highest CPP/attenuator interaction, predicting minimized cellular uptake until cleaved. The in vitro MMP-14-mediated cleavage studies using the human recombinant MMP-14 catalytic domain revealed an enhanced cleavage rate that directly correlated with the linearity of the embedded peptide substrate sequence. Successful cleavage and uptake of a technetium-99m labeled version of the optimal probe was demonstrated in MMP-14 transfected human breast cancer cells. Two-fold reduction of cellular uptake was found in the presence of a broad spectrum MMP inhibitor. The combination of computational chemistry, parallel synthesis and biochemical screening, therefore, shows promise as a set of tools for developing new radiolabeled probes that are sensitive to protease activity.

Download full-text


Available from: Ken A Dill,
  • Source
    • "The resulting imaging probe was a kind of smart probe containing a MMP-2 peptide substrate with quenched nearinfrared fluorochromes that are cleaved upon recognition by the MMP [88]. Recently, an activatable SPECT imaging probe specific for MMP- 14 using a cell penetrating peptide as the retention moiety in the cells after MMP recognition was reported to be partly successful in in vitro experiments [89]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease is the leading cause of death worldwide. Unstable atherosclerotic plaques are prone to rupture followed by thrombus formation, vessel stenosis, and occlusion and frequently lead to acute myocardial infarction and brain infarction. As such, unstable plaques represent an important diagnostic target in clinical settings and the specific diagnosis of unstable plaques would enable preventive treatments for cardiovascular disease. To date, various imaging methods such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound (US), and intravascular ultrasound (IVUS) have been widely used clinically. Although these methods have advantages in terms of spatial resolution and the ability to make detailed identification of morphological alterations such as calcifications and vessel stenosis, these techniques require skill or expertise to discriminate plaque instability, which is essential for early diagnosis and treatment and can present difficulties for quantitative estimation. On the other hand, nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) can noninvasively collect quantitative information on the expression levels of functional molecules and metabolic activities in vivo and thus provide functional diagnoses of unstable plaques with high sensitivity. Specifically, unstable plaques are characterized by an abundance of invasive inflammatory cells (macrophages), increased oxidative stress that increases oxidized LDL and its receptor expressed on cells in the lesions, increased occurrence of apoptosis of macrophages and other cells involved in disease progression, increased protease expression and activity, and finally thrombus formation triggered by plaque rupture, which is the most important mechanism leading to the onset of infarctions and ischemic sudden death. Therefore, these characteristics can all be targets for molecular imaging by PET and SPECT. In this paper, we review the present state and future of radiolabelled probes that have been developed for detecting atherosclerotic unstable plaques with nuclear imaging techniques.
    American Journal of Nuclear Medicine and Molecular Imaging 11/2012; 2(4):432-47. · 3.25 Impact Factor
  • Source
    • "In another strategy, a MT1-MMP-activated single photon emission computed tomography (SPECT) imaging probe was constructed by fusing a radionuclide to an inhibited cell penetrating peptide (CPP) to selectively target MT1-MMP expressing cells. However, the probe was also activated in cells that do not express MT1-MMP, indicating non-specific cleavage of the MT1-MMP substrate by other MMPs (Watkins et al., 2009). Thus the specific detection of MT1-MMP activity in cell culture and in vivo will require substrates with improved activity and selectivity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Directed evolution was applied to identify peptide substrates with enhanced hydrolysis rates by MT1-MMP suitable for protease beacon development. Screening of a random pentapeptide library, using two-color CLiPS, yielded several substrates identical to motifs in distinct collagens that shared the consensus sequence P-x-G↓L. To identify substrates with enhanced cleavage rates, a second-generation decapeptide library incorporating the consensus was screened under stringent conditions, which resulted in a MxPLG↓(M)/(L)M(G)/(A)R consensus motif. These substrates are hydrolyzed by human-MT1-MMP up to six times faster than reported peptide substrates and are stable in plasma. Finally, incubation of soluble protease beacons incorporating the optimized substrates, but not previous substrates, enabled direct detection of endogenous MT1-MMP activity of human-fibrosarcoma (HT-1080) cells. Extended substrate libraries coupled with CLiPS should be useful to generate more effective activity probes for a variety of proteolytic enzymes.
    Chemistry & biology 03/2011; 18(3):392-401. DOI:10.1016/j.chembiol.2010.12.017 · 6.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: For creation of planar and fiber amplifiers, the up-conversion processes in Er-doped glasses should be taken into account. We consider the up-conversion transition in a pair of Er3+ions, when in initial state both the ions are at the 4I13/2level, and in final state one ion is at the 4I15/2 ground level and other at the 4I 9/2 level
    Conference Proceedings - Lasers and Electro-Optics Society Annual Meeting-LEOS 01/1997; 2. DOI:10.1109/LEOS.1997.645439
Show more